Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-26

Clinical Trial Update: Rapid Antidepressant Effects of Leucine [Phase 2]

View source ↗

Summary

Phase 2 trial investigating rapid antidepressant effects of leucine in adults with major depressive disorder; study terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucine (Leucine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Major Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2023-01-26